You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

India's Pharma Majors See Huge HCQ Export Potential, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 179 Words
Attachment: India HCQ 0420

India's leading pharmaceutical companies, including Zydus Cadila and Ipca Laboratories, have started increasing production of the antimalarial drug hydroxychloroquine (HCQ), which has been touted by U.S. President Donald Trump and others as a potential treatment for COVID-19. Its status in regards to COVID-19 remains a topic of debate among health professionals.

Subscribe Now! All Fields Required...

Standard Membership - Free